Back

Longitudinal Neurocognitive Trajectories in a Large Cohort of Youth Who Use Cannabis: Combining Self-Report and Toxicology

Wade, N. E.; Sullivan, R. M.; Wallace, A. L.; Visontay, R.; Szpak, V.; Lisdahl, K. M.; Huestis, M. A.; Goncalves, P. D.; Byrne, H.; Mewton, L.; Jacobus, J.; Tapert, S. F.

2026-03-06 neuroscience
10.64898/2025.12.20.695698 bioRxiv
Show abstract

Adolescents experience extensive neurocognitive development, with cannabis use potentially impacting developmental trajectories. Here, we comprehensively assess the influence of adolescent cannabis use onset on neurocognitive trajectories and consider how recent delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) may influence neurocognition. We use the large, diverse longitudinal Adolescent Brain Cognitive Development (ABCD) Study dataset, combining self-reported substance use with objective toxicological tests (hair, urine, breath, oral fluid). Longitudinal mixed methods of the full cohort (n=11,036, ages 9-17; 47% Female/53% Male) investigate time-varying cannabis onset on neurocognitive performance. Primary model covariates include sociodemographics, family history of substance use disorder, prenatal substance exposure, early psychopathology, other substance use, and nesting for participant ID, study site, and family ID. Secondarily, in participants with repeat toxicological hair testing (n=645; 38% Female/62% Male) at ages 12-16, we consider the influence of THC v. CBD v. Controls. Primary models included false discovery rate corrections (FDR-p<.05) while secondary models were interpreted at p<.01. Cannabis group interacted with age to show altered neurocognitive trajectories across domains (immediate recall and delayed memory, processing speed, inhibitory control, visuospatial processing, language, and working memory; {beta}s=-0.11- - 0.52). Secondary models indicated hair-identified THC exposure*age predicted worse episodic memory than in Controls ({beta}=-0.60, p=.007), with no difference between CBD exposed and Controls. Data suggest those who use cannabis show likely pre-existing better cognitive performance during late childhood, with reduced improvement or flattened trajectories over time. These neurocognitive trajectories in youth (ages 9-17) who initiate cannabis use were demonstrated after accounting for within-person change and numerous known confounds and improving accuracy in identifying cannabis use through incorporating toxicological measures. Continued monitoring of this cohort will clarify cannabinoid-cognition relationships into young adulthood, including the impact of timing of cannabis use initiation.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Neuropsychopharmacology
134 papers in training set
Top 0.1%
18.8%
2
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 0.2%
6.9%
3
Addiction Biology
47 papers in training set
Top 0.2%
6.4%
4
Drug and Alcohol Dependence
37 papers in training set
Top 0.2%
4.9%
5
Biological Psychiatry Global Open Science
54 papers in training set
Top 0.2%
3.6%
6
Frontiers in Behavioral Neuroscience
46 papers in training set
Top 0.2%
3.6%
7
Translational Psychiatry
219 papers in training set
Top 2%
3.6%
8
Biological Psychiatry
119 papers in training set
Top 0.9%
3.6%
50% of probability mass above
9
eneuro
389 papers in training set
Top 3%
3.6%
10
Alcoholism: Clinical and Experimental Research
13 papers in training set
Top 0.1%
2.7%
11
Psychopharmacology
59 papers in training set
Top 0.3%
2.1%
12
Psychological Medicine
74 papers in training set
Top 0.8%
1.9%
13
Scientific Reports
3102 papers in training set
Top 55%
1.8%
14
eLife
5422 papers in training set
Top 41%
1.7%
15
PLOS ONE
4510 papers in training set
Top 53%
1.7%
16
Addiction
25 papers in training set
Top 0.3%
1.7%
17
NeuroImage: Clinical
132 papers in training set
Top 3%
1.3%
18
Developmental Cognitive Neuroscience
81 papers in training set
Top 0.4%
1.3%
19
Alcohol, Clinical and Experimental Research
12 papers in training set
Top 0.2%
1.3%
20
Neuroscience & Biobehavioral Reviews
43 papers in training set
Top 0.5%
1.3%
21
JAMA Psychiatry
13 papers in training set
Top 0.3%
1.3%
22
Addiction Neuroscience
17 papers in training set
Top 0.4%
1.2%
23
Nature Human Behaviour
85 papers in training set
Top 3%
1.2%
24
Journal of Child Psychology and Psychiatry
25 papers in training set
Top 0.3%
1.1%
25
Nicotine and Tobacco Research
13 papers in training set
Top 0.2%
0.8%
26
Nature Mental Health
18 papers in training set
Top 0.3%
0.8%
27
The Journal of Neuroscience
928 papers in training set
Top 8%
0.8%
28
NeuroImage
813 papers in training set
Top 6%
0.8%
29
Molecular Psychiatry
242 papers in training set
Top 3%
0.8%
30
Behavioral Neuroscience
25 papers in training set
Top 0.3%
0.7%